Figure 2
![Figure 2. Plasma ADMA levels in polycythemia vera patients. Plasma ADMA levels in the entire patient population (n = 37), divided according to the ongoing treat-ment (aspirin [ASA] alone, aspirin plus phlebothomy [Phl], or plus hydroxyurea [HU], as well as in healthy controls (n = 12). ● represents patients with previous thrombotic events.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/112/4/10.1182_blood-2007-11-123091/6/zh80170822910002.jpeg?Expires=1722412071&Signature=tCg2g8uHSOQ76eQ0syoIMjElCFCcZ77cj8u5DJT9ojG~wfHgxHs8qxosMz98C4RJWAgfBaTwIKLK7SQYH4NxONnpz3WgN4oesLzMO3o6qzEd0OcmnX6zcPSPCD-POioX~QbKzBWMDkjlTPW7uMKDEu194pw7F-d7FDxZb2FAoVJym2XshhYH-l7kdodEBumg6qm~X5VVRTUGm4dTjCVbcwezhJLjAb0nKk2Y95O9G-Vjc34So51JtBcxBziLvj-cqc7jR2EtMZCXAlLoo0e2bDagtyMHaKOMgmT64id5QhsIQfYRSzCBOSTbu~53zJMwtZN-g2rMBdwHgiCc-XGmGg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Plasma ADMA levels in polycythemia vera patients. Plasma ADMA levels in the entire patient population (n = 37), divided according to the ongoing treat-ment (aspirin [ASA] alone, aspirin plus phlebothomy [Phl], or plus hydroxyurea [HU], as well as in healthy controls (n = 12). ● represents patients with previous thrombotic events.
